CALASPARGASE PEGOL-MKNL for B precursor type acute leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where CALASPARGASE PEGOL-MKNL was used for B precursor type acute leukaemia.
Most Reported Side Effects for CALASPARGASE PEGOL-MKNL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hypersensitivity | 155 | 30.7% | 0 | 28 |
| Anaphylactic reaction | 76 | 15.1% | 0 | 40 |
| Pancreatitis | 56 | 11.1% | 3 | 26 |
| Infusion related reaction | 51 | 10.1% | 0 | 24 |
| Vomiting | 37 | 7.3% | 2 | 21 |
| Tachycardia | 20 | 4.0% | 2 | 13 |
| Nausea | 19 | 3.8% | 0 | 9 |
| Cough | 18 | 3.6% | 0 | 13 |
| Hypertriglyceridaemia | 18 | 3.6% | 1 | 10 |
| Neutropenia | 15 | 3.0% | 2 | 5 |
| Venoocclusive liver disease | 15 | 3.0% | 5 | 13 |
| Septic shock | 14 | 2.8% | 6 | 11 |
| Pancreatitis acute | 13 | 2.6% | 0 | 9 |
| Abdominal pain | 12 | 2.4% | 0 | 9 |
| Hyperglycaemia | 12 | 2.4% | 1 | 5 |
Other Indications for CALASPARGASE PEGOL-MKNL
Acute lymphocytic leukaemia (156)
Product used for unknown indication (122)
B-cell type acute leukaemia (84)
T-cell type acute leukaemia (29)
Leukaemia (11)
T-cell lymphoma (7)
Precursor t-lymphoblastic lymphoma/leukaemia (6)
Ductal adenocarcinoma of pancreas (5)
Non-hodgkin's lymphoma (5)
Other Drugs Used for B precursor type acute leukaemia
BLINATUMOMAB (1,791)
METHOTREXATE (1,067)
VINCRISTINE (977)
DEXAMETHASONE (662)
CYTARABINE (644)
CYCLOPHOSPHAMIDE (598)
PEGASPARGASE (531)
MERCAPTOPURINE (484)
DOXORUBICIN (331)
DAUNORUBICIN (274)